Financial News

Financial Report: Thermo Fischer Scientific

Laboratory Products and Services Segment revenue up 42% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fischer Scientific
1Q Revenues: $5.9 billion (+23%)
1Q Earnings: $579 million (+5%)
Comments: Laboratory Products and Services Segment revenue grew 42% to $2.4 billion, reflecting the acquisition of Patheon in late August 2017. Life Sciences Solutions Segment revenue grew 10% to $1.5 billion. Analytical Instruments Segment revenue grew 19% to $1.3 billion. Specialty Diagnostics Segment revenue grew 9% to $0.95 billion. The company launched new products across our portfolio, including Thermo Scientific Vanquish Duo UHPLC systems for pharma QA/QC, the Thermo Scientific Chromeleon XTR Laboratory Management System and the Ion GeneStudio S5 Series of next-generation sequencing instruments. Acquisitions increased revenue by 12% in the quarter.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters